Navigation Links
IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
Date:3/27/2008

delivery technologies, to formulate both generic and new drug products with enhanced performance characteristics. In addition to its pre-clinical portfolio, IntelliPharmaCeutics has an extensive pipeline of development products in clinical trials, in therapeutic areas that include neurology, cardiovascular, GIT, and pain. For more information about IntelliPharmaCeutics, visit the Company's web site at http://www.intellipharmaceutics.com.

This news release contains forward-looking statements, including those related to the preliminary nature of clinical program results and the potential for further product development, that involve known and unknown risks, delays, uncertainties and other factors not under the control of IntelliPharmaCeutics, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these forward-looking statements. In particular, because substantial future clinical testing and regulatory review will be required prior to marketing approval, there can be no certainty that a successful commercial product will be developed. The Company undertakes no obligation to update any forward-looking statements.


'/>"/>
SOURCE IntelliPharmaCeutics Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...5 /- Lentigen Corporation announced t... of Health (NIH) small,business innovation researc...ists. Through these grants, Lentigen will apply it... the development of novel,immunotherapeutic treatm...-- Melanoma, with Michael Nishimura, Ph.D, Associa...
(Date:5/15/2008)...any Focused on Commercialization in 2008 -, FREMO...llion, Inc.,(Nasdaq: VRML ), a molecular diagnost... the first quarter ended March 31, 2008, and provi...elopments., "During the first quarter of 2008, we...zation progress in each of our diagnostic programs...
(Date:5/15/2008)...ay 15 /- Nile Therapeutics,...results for the first quarter,ended March 31, 2008...08 was $3.1 million, or,$0.13 per share, compared ... quarter of 2007. Weighted average shares outstand...4.1 million and 13.8 million, respectively., Nile...
(Date:5/15/2008)... /- American Oriental,Bioen...mpany dedicated to,improving health through the de...broad range of prescription and over the counter (...wing statement regarding the earthquake in,China:,...,s earthquake and we,are thankful to report that n...
Breaking Biology Technology:Lentigen Corporation Receives Four Research Grants From the National Institutes of Health 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 3Vermillion Announces First Quarter 2008 Financial Results and Business Progress 4Vermillion Announces First Quarter 2008 Financial Results and Business Progress 5Vermillion Announces First Quarter 2008 Financial Results and Business Progress 6Vermillion Announces First Quarter 2008 Financial Results and Business Progress 7Vermillion Announces First Quarter 2008 Financial Results and Business Progress 8Vermillion Announces First Quarter 2008 Financial Results and Business Progress 9Nile Therapeutics Reports 2008 First Quarter Financial Results 2Nile Therapeutics Reports 2008 First Quarter Financial Results 3American Oriental Bioengineering Comments on Earthquake 2
...adison, Wis. - Jason Smith acknowledges he,s on a... Fund Midwest , a sector fund of the Peak Ridge Ca...idwest and the East Coast venture communities, and...n technology companies is one of the reasons that ...g and it is one of the first things I think about,...
...ilwaukee, Wis. - Broadlook Technologies , an Int...el, Gregory Meier, as the firm,s chief operations ...private equity, and venture capital sectors, and h...sed Broadlook grow through sales, marketing, and b...g, and he believed in our vision five years ago wh...
...adison, Wis. - A University of Wisconsin-Madison... students the fourth-fastest financial return in t...Best B-Schools " issue. , ,On average, the UW clas... earning salaries $42,343 higher than before. A gr...not counting lost income for full-time students. ,...
...have been closely following the progress of the H... (HIPAA) and electronic health records for the la...m a practicing dentist with a small healthcare bus...am what they call a "stakeholder" in this exciting...andate. , ,More important than my job, I am a hus...
Other Biology Technology:Investor links East Coast funds to Midwest tech 2Investor links East Coast funds to Midwest tech 3UW-Madison MBA program ranked among best for investment return 2Careful with that electronic health record, Mr. Leavitt 2Careful with that electronic health record, Mr. Leavitt 3Careful with that electronic health record, Mr. Leavitt 4
(Date:5/15/2008)... May 15, 2008 (BRONX, NY) Contrary to long-held... risk of death, according to investigators from th...niversity. They reached their conclusion after exa...ative sample of adults in the U.S. The Einstein re...sed risk of death from cardiovascular disease (CVD...
(Date:5/15/2008)... Argonne, Ill. (May 15, 2008) Argonne National L... (MOU) with Savannah River National Laboratory (SR...ntal management research projects in support of cr...r important national priorities. , "The MOU allo...search," Argonne director Robert Rosner said. "Arg...
(Date:5/15/2008)... Fishermen hold empirical knowledge that tuna agg...old rope, pieces of wood, or even large marine mam...aggregation behaviour, but the past 20 years have ...of the associated concentrations of fish. Fisherme...h act as FADs. An enormous purse-seine net, deploy...
(Date:5/14/2008)... Intelligent Wireless Module Combines Linux, Se... Consumption, TUSTIN, Calif., May 14 /PRNewswire/...n intelligent high-performance module designed for...tion to 802.11a/b/g wireless local,area networks (...at need,WLAN connectivity with minimal power usage...
Breaking Biology News(10 mins):New study casts further doubt on risk of death from higher salt intake 2Argonne-SRNL agreement supports critical DOE, national priorities 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 3New Silex SX-560 Enables Enterprise 802.11 Wireless Connectivity for Battery Operated Devices 2Wiley Blackwell renews carbon neutral commitment 12424 1Taking Multiple Pain Relievers May Cause Complications 12419 1Taking Multiple Pain Relievers May Cause Complications 12419 2Patients relatives are ignored by the health system and suffer emotional stress 12416 1Patients relatives are ignored by the health system and suffer emotional stress 12416 2Former Biolase CEO 26 EVP Launch Technology4Medicine 12411 1Former Biolase CEO 26 EVP Launch Technology4Medicine 12411 2
... have developed a customized gene chip to rapidly ...ffer clues to prognosis in cases of neuroblastoma,...overing the entire genome, the microarray focuses ...eted genetic material known to play a role in the ...ospital of Philadelphia and Thomas Jefferson Unive...
... people often die. That,s why a lot of cancer rese...t allow cancer to metastasize -- to spread from on...ty researchers have now furthered understanding of... future research on drug therapies that disrupt th...study published in the journal Developmental Cell ...
...r the development of strong, healthy crops. But un...the development of roots was still a mystery. Scie... for Biotechnology (VIB) connected to Ghent Univer...order to identify the genes that are essential for...ime, they are unraveling the genetic basis for the...
...a scientists used a healthy human gene to prevent ...disease that strikes boys. , Writing in the Augus...UF Genetics Institute describe how they successful...s, a rare genetic disorder that is passed from mot...rrently there is no treatment," said William Hausw...
Other Biology News:Customized gene chip provides rapid detection of genetic changes in children's cancer 2Customized gene chip provides rapid detection of genetic changes in children's cancer 3Researcher uncovers details of how cancer spreads 2Plant genes identified that can form basis for crops better adapted to environmental conditions 2Gene therapy works in mice to prevent blindness that strikes boys 2Gene therapy works in mice to prevent blindness that strikes boys 3
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
The 12-Tube Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: 12 microcentrifuge tubes. ,Magnets: Neodymium rare earth permanent ma
Single Place Magnetic Stand from Ambion
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST).
Biology Products: